hepatitis C

Teva Plans Appeal of Award in Hepatitis Case
NY Times, NY
Mon, 05/10/10 - 11:54 am
Teva Pharmaceuticals
appeals
hepatitis C
propofol
Drugmakers Lose Hepatitis C Trial
Pharmalot
Fri, 05/7/10 - 08:31 am
hepatitis C
Teva Pharmaceuticals
Baxter International
Hepatitis C Resists Vertex Drug, Needs Cocktails
Bloomberg
Thu, 05/6/10 - 07:01 am
Vertex Pharmaceuticals
hepatitis C
Gilead Sciences halts hepatitis C drug trials
Bizjournals.com
Tue, 04/20/10 - 10:44 am
Gilead Sciences
clinical trials
hepatitis C
Warehoused Hepatitis C Patients May Boost Merck, J&J and Vertex
Bloomberg
Mon, 04/19/10 - 11:32 am
hepatitis C
JNJ
Merck
Vertex Pharmaceuticals
Human Genome Sciences' partner Novartis pulls European application for hepatitis C drug
Yahoo/AP
Mon, 04/19/10 - 11:08 am
Human Genome Sciences
Novartis
Joulferon
Europe
hepatitis C
Oops, This Drug Works Too Well
Motley Fool
Thu, 04/15/10 - 08:42 am
Roche
InterMune
danoprevir
hepatitis C
Inovio, Drexel, Penn and Cheyney get grant to develop hepatitis C vaccine Read more: Inovio, Drexel, Penn and Cheyney get grant to develop hepatitis C vaccine - Philadelphia Business Journal:
bizjournals.com
Sat, 04/10/10 - 12:15 pm
Inovio
hepatitis C
Human Genome Sciences reports hepatitis drug study
Yahoo/AP
Wed, 03/24/10 - 10:47 am
Human Genome Sciences
Zalbin
hepatitis C
Anadys study results show little difference between hepatitis C drug, placebo; shares slide
Yahoo/AP
Thu, 02/25/10 - 09:06 am
hepatitis C
Anadys
Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Medical News Today
Sat, 01/23/10 - 11:29 am
Anadys
hepatitis C
Achillion shares rocket up on promising hep C data
Fierce Biotech
Wed, 12/16/09 - 11:32 am
Achillion
hepatitis C
InterMune Hep C Drug Hit With Liver Tox Worry
TheStreet.com
Tue, 11/17/09 - 11:07 am
hepatitis C
InterMune
Schering-Plough reports data on hepatitis C drug
Yahoo/AP
Mon, 11/2/09 - 08:34 am
Boceprevir
Schering Plough
hepatitis C
Vertex Hep C Drug Cures 80% at New Dose: Study
The Street
Sun, 11/1/09 - 09:08 am
Vertex Pharmaceuticals
Telaprevir
hepatitis C
Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
Yahoo/Business Wire
Sun, 11/1/09 - 09:04 am
Bristol-Myers Squibb
ZymoGenetics
hepatitis C
Novartis not licensing Idenix's hepatitis C drug
Yahoo/AP
Fri, 10/30/09 - 10:00 am
Novartis
Idenix
hepatitis C
Vertex Hep C Drug Improves Cure Rates
TheStreet.com
Wed, 10/28/09 - 07:39 am
hepatitis C
Vertex Pharmaceuticals
Telaprevir
Human Genome Sciences gets milestone payment for development of hepatitis C drug Zalbin
Yahoo/AP
Mon, 10/19/09 - 07:57 am
hepatitis C
Zalbin
Novartis
Human Genome Sciences
Analyst upgrades Pharmasset, citing potential for developing hepatitis C drug
Yahoo/AP
Tue, 09/8/09 - 09:06 am
Pharmasset
upgrades
hepatitis C

Pages